Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning …
JE Van Leeuwen, MJ Van Tol, AM Joosten, JT Wijnen… - 1994 - ashpublications.org
We investigated the chimerism pattern within flow-sorted peripheral blood-or bone marrow-
derived cell populations after allogeneic bone marrow transplantation (BMT) for the …
derived cell populations after allogeneic bone marrow transplantation (BMT) for the …
Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse
JE Van Leeuwen, MJ Van Tol, AM Joosten, JT Wijnen… - 1993 - ashpublications.org
We performed polymerase chain reaction-variable number of tandem repeats analysis of
flow-sorted peripheral blood T-, B-, natural killer-, and myeloid cell populations (van …
flow-sorted peripheral blood T-, B-, natural killer-, and myeloid cell populations (van …
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed …
P Bader, T Klingebiel, A Schaudt, U Theurer-Mainka… - Leukemia, 1999 - nature.com
The success of allogeneic stem cell transplantation (allo-SCT) in children is mainly affected
by relapse or graft rejection. We have recently shown in a study of 55 patients with acute …
by relapse or graft rejection. We have recently shown in a study of 55 patients with acute …
Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: A review of recent …
K Miyamura, AJ Barrett, Y Kodera… - Bone Marrow …, 1994 - europepmc.org
Cure of leukemia by allogeneic BMT is achieved by the combined effect of the myeloablative
preparative regimen and an allo-immune response of donor cells to residual leukemia …
preparative regimen and an allo-immune response of donor cells to residual leukemia …
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous …
G Pichert, DC Roy, R Gonin, EP Alyea… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE Allogeneic bone marrow transplantation (BMT) has been shown to provide
effective therapy for chronic myelogenous leukemia (CML), but previous reports have also …
effective therapy for chronic myelogenous leukemia (CML), but previous reports have also …
Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia.
M Ramirez, MA Diaz, F Garcia-Sanchez… - Bone marrow …, 1996 - europepmc.org
Leukemic relapse after allogeneic bone marrow transplantation or allogeneic peripheral
blood progenitor cell transplantation arises normally from residual malignant host …
blood progenitor cell transplantation arises normally from residual malignant host …
[HTML][HTML] Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors
K Molloy, N Goulden, M Lawler, J Cornish, A Oakhill… - Blood, 1996 - Elsevier
Hematopoietic chimerism was analyzed in serial bone marrow samples taken from 28
children following T-cell depleted unrelated donor bone marrow transplants (UD BMT) for …
children following T-cell depleted unrelated donor bone marrow transplants (UD BMT) for …
Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes
K Kishi, S Takahashi, H Gondo, S Shiobara… - Bone marrow …, 1997 - nature.com
To assess the consequence of second BMT (BMT2) for leukemia relapse after allogeneic
BMT, we analyzed the clinical course of 66 recipients who were treated by BMT2 in Japan …
BMT, we analyzed the clinical course of 66 recipients who were treated by BMT2 in Japan …
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
S Slavin, E Naparstek, A Nagler, A Ackerstein… - 1996 - ashpublications.org
Allogeneic bone marrow transplantation (BMT) is the only effective treatment for hematologic
malignancies resistant to conventional chemotherapy. Until recently, no cure existed for …
malignancies resistant to conventional chemotherapy. Until recently, no cure existed for …
Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to …
P Bader, J Beck, PG Schlegel… - Bone marrow …, 1997 - nature.com
The success of allogeneic BMT (allo-BMT) in children with acute leukemias is mainly
affected by relapse. There is evidence that these patients have only a little or no benefit from …
affected by relapse. There is evidence that these patients have only a little or no benefit from …